NYSE: GPC

GENUINE PARTS CO

CIK 0000040987 · SIC 5013 · Motor Vehicle Supplies

Mega Revenue $24.3B Assets $21.5B as of Oct 21, 2026

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (WAB 10-Q) is open in full — no account needed.

10-Q Filed Oct 20, 2026 · Period ending Sep 30, 2026

Net sales rose 4.2% to $6.52B in the fiscal third quarter, while net income slipped 0.8% to $224.4M as restructuring and separation costs weighed on results.

5 material changes detected. Sign up free to read the summary.

8-K Filed Oct 20, 2026 · Period ending Oct 20, 2026

Summary not yet generated.

Partner

Trade GPC commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

8-K Filed Sep 9, 2026 · Period ending Sep 4, 2026

Summary not yet generated.

8-K Filed Aug 11, 2026 · Period ending Aug 11, 2026

Summary not yet generated.

10-Q Filed Jul 21, 2026 · Period ending Jun 30, 2026

Summary not yet generated.

10-K Filed Feb 20, 2026 · Period ending Dec 31, 2025

Summary not yet generated.

10-Q Filed Oct 21, 2025 · Period ending Sep 30, 2025

Summary not yet generated.

10-K Filed Feb 21, 2025 · Period ending Dec 31, 2024

Summary not yet generated.

424B5 Filed Aug 9, 2024

Summary not yet generated.

424B5 Filed Aug 7, 2024

Summary not yet generated.

424B5 Filed Oct 25, 2023

Summary not yet generated.

10-Q/A Filed Aug 9, 2019 · Period ending Jun 30, 2019

Summary not yet generated.

10-K/A Filed Aug 9, 2019 · Period ending Aug 9, 2019

Summary not yet generated.

Latest financial statements

From 10-Q filed Oct 20, 2026 (period ending Sep 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Condensed Consolidated Statements of Income (Unaudited)

(in thousands, except per share data)

Description Three months ended September 30, 2026 Three months ended September 30, 2025 Nine months ended September 30, 2026 Nine months ended September 30, 2025
Net sales 6,521,308 6,260,232 19,323,199 18,290,726
Cost of goods sold 4,037,033 3,918,830 12,029,253 11,451,252
Gross profit 2,484,275 2,341,402 7,293,946 6,839,474
Operating expenses:
Selling, administrative and other expenses 1,944,518 1,805,928 5,718,856 5,286,802
Depreciation and amortization 137,490 127,475 403,234 365,928
Provision for doubtful accounts 9,238 6,871 27,339 20,351
Restructuring and other costs 64,545 66,835 193,426 167,317
Total operating expenses 2,155,791 2,007,109 6,342,855 5,840,398
Non-operating expense (income):
Interest expense, net 45,970 40,342 135,723 117,769
Other 3,866 2,258 (2,503) (580)
Total non-operating expense 49,836 42,600 133,220 117,189
Income before income taxes 278,648 291,693 817,871 881,887
Income taxes 54,201 65,522 177,331 206,444
Net income 224,447 226,171 640,540 675,443
Basic earnings per share 1.63 1.63 4.65 4.86
Diluted earnings per share 1.62 1.62 4.64 4.85

Condensed Consolidated Balance Sheets (Unaudited)

(in thousands, except share and per share data)

Description September 30, 2026 December 31, 2025
Assets
Current assets:
Cash and cash equivalents 763,151 477,179
Trade accounts receivable, less allowance for doubtful accounts (2026 $92,230; 2025 – $85,537) 2,619,491 2,370,939
Merchandise inventories, net 6,435,802 6,071,996
Prepaid expenses and other current assets 1,632,361 1,644,620
Total current assets 11,450,805 10,564,734
Goodwill 3,206,231 3,188,815
Other intangible assets, less accumulated amortization 1,743,938 1,855,714
Property, plant and equipment, less accumulated depreciation (2026 $2,349,284; 2025 – $2,137,108) 2,161,387 2,172,140
Operating lease assets 2,062,454 2,084,487
Other assets 872,340 929,650
Total assets 21,497,155 20,795,540
Liabilities and equity
Current liabilities:
Trade accounts payable 6,394,876 6,051,882
Short-term borrowings 388,088 943,540
Current portion of long-term debt 250,000 353,788
Dividends payable 148,074 143,291
Other current liabilities 2,180,515 2,295,204
Total current liabilities 9,361,553 9,787,705
Long-term debt 4,472,149 3,498,423
Operating lease liabilities 1,713,902 1,739,478
Pension and other post–retirement benefit liabilities 218,787 219,270
Deferred tax liabilities 368,353 385,948
Other long-term liabilities 703,492 724,353
Equity:
Preferred stock, par value $1 per share; authorized – 10,000,000 shares; none issued — —
Common stock, par value $1 per share; authorized – 450,000,000 shares; issued and outstanding – 2026 – 137,864,682 shares; 2025 – 137,617,832 shares 137,865 137,618
Additional paid-in capital 259,505 228,370
Accumulated other comprehensive loss (518,474) (511,766)
Retained earnings 4,770,080 4,568,769
Total parent equity 4,648,976 4,422,991
Noncontrolling interests in subsidiaries 9,943 17,372
Total equity 4,658,919 4,440,363
Total liabilities and equity 21,497,155 20,795,540

Condensed Consolidated Statements of Cash Flows (Unaudited)

(in thousands)

Description Nine months ended September 30, 2026 Nine months ended September 30, 2025
Operating activities:
Net income 640,540 675,443
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization 403,234 365,928
Share-based compensation 45,095 37,183
Other operating activities, including changes in operating assets and liabilities (272,222) (567,865)
Net cash provided by operating activities 816,647 510,689
Investing activities:
Purchases of property, plant and equipment (314,476) (350,443)
Proceeds from sale of property, plant and equipment 28,070 21,085
Acquisitions of businesses (69,450) (181,987)
Proceeds from divestitures of businesses 6,885 59
Other investing activities (12,105) 23,335
Net cash used in investing activities (361,076) (487,951)
Financing activities:
Proceeds from debt 1,291,217 44,600
Payments on debt (997,776) (567,368)
Net proceeds of commercial paper 44,968 886,175
Shares issued from employee incentive plans (13,713) (16,316)
Dividends paid (434,446) (420,571)
Other financing activities (29,283) (20,237)
Net cash used in financing activities (139,033) (93,717)
Effect of exchange rate changes on cash and cash equivalents (30,566) 22,347
Net increase (decrease) in cash and cash equivalents 285,972 (48,632)
Cash and cash equivalents at beginning of period 477,179 479,991
Cash and cash equivalents at end of period 763,151 431,359

Amounts as printed on the EDGAR/iXBRL face — (in thousands, except per share data); (in thousands, except share and per share data); (in thousands). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗

View AI report for this filing